~ Study Finds Elevated Homocysteine More Than Doubled Heart Attack Risk In High Risk Patients
A report scheduled to be published in 2007 appearing early online in the journal Cardiology revealed that having an above average total homocysteine level increases the risk of a coronary event among men and women with atherosclerosis by a factor of 2.5.
The current study involved participants in the Benzafibrate Infarction Prevention Study which evaluated the effect of benzafibrate for secondary prevention of coronary events in 3,090 men and women with chronic heart disease, defined as a history of heart attack or angina. Dr Moti Haim, of the Rabin Medical Center in Petah Tikva and his colleagues in Israel matched 69 subjects who experienced fatal or nonfatal heart attack, or sudden death with an equal number of participants who remained free of recurrent coronary events or stroke throughout the 4.7 to 7.6 year follow-up period. Blood samples were analyzed at the beginning of the study for lipids, fibrinogen, blood chemistry and other factors, and total homocysteine concentrations were measured in frozen serum samples obtained at the beginning of the study.
The median total homocysteine among individuals with recurrent coronary events was 15.2 micromoles per liter compared to 12.9 micromoles per liter in the control group, with a median of differences between the matched pairs of subjects of 3.95 micromoles per liter. Individuals whose homocysteine levels were in the top one-third of participants experienced a 2.5 times greater risk of a coronary event or sudden death than those whose values were in the lowest third.
In the present study, we provided evidence that in patients with preexisting vascular disease, there is an association between total homocysteine concentration and incidence of coronary events, which is independent of traditional risk factors and inflammatory markers, the authors write. They note that not all studies have found the same association, and hypothesize that elevated homocysteine could be a strong predictor of coronary events in high risk patients but not low risk ones. Furthermore, they could not conclude whether homocysteine was a causative factor or bystander marker of cardiovascular risk. If total homocysteine level is causally related to CHD risk, then our findings suggest that patients with preexisting vascular disease may have a greater potential benefit from interventions that lower homocysteine concentrations, they observe.
Related Health Concern: Homocysteine Reduction
The evidence is clear that having an elevated homocysteine level is an independent risk factor for heart disease. One large study conducted among physicians who had no history of heart disease showed that having a highly elevated homocysteine level was associated with a more than 3-fold increase in the risk of heart attack over a 5-year period (Stampfer MJ et al 1992).
It is important to begin your homocysteine-lowering program by working with a qualified physician and taking the necessary blood tests to evaluate your risk. To help lower your homocysteine level, the Life Extension Foundation suggests:
- Folic acid 4000 to 8000 mcg daily
- Vitamin B12 1 to 2 mg daily
- Vitamin B6 100 to 200 mg daily
- SAMe 400 mg two to four times daily
- TMG 2 to 4 grams daily
- Zinc 30 to 90 mg daily
- CDP choline 250 to 500 mg daily. Alternatively, you can use 1 to 3 teaspoons of liquid choline chloride daily mixed with 2 ounces of juice, 1 tablespoon of pure lecithin granules daily, or 250 mg of a-GPC daily.
- Micronized creatine 500 mg (in capsule form) four to eight times daily
- N-acetyl-cysteine 600 mg (in capsule form) one to two times daily on an empty stomach
If this protocol is not successful at lowering homocysteine level, a weekly 1-mg vitamin B12 injection may be necessary (this requires a prescription).
Related Products and Information
Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.
While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.